ACADIA Pharmaceuticals, Inc. (ACAD)

dockofthebay (< 20) Submitted: 4/17/07 3:36 PM : Start Price: $15.69 ACAD Score: -64.09

ACP 103 as co-therapy with low dose Risperdal met endpoint with ease.These results shold be duplicated in Phase III,given the margin of statistical significance in Phase II. With higher dose of Risperdal, efficacy was achieved sooner and with less we...

Report this Post Replies: 1 | Reply | Permalink

zzlangerhans (78.80) Submitted: 9/27/07 1:43 AM : Start Price: $15.28 ACAD Score: -60.21

I like the way this company is advancing its two major products aggressively. Positive catalysts within next year are interim data for phase III trial of pimavanserin and phase IIb trial of ACP-104. Company also has other drugs in early development.

Report this Post Replies: 0 | Reply | Permalink

daviddai (< 20) Submitted: 3/20/07 2:51 AM : Start Price: $13.24 ACAD Score: -64.29

1. More candidates!! The drug maker's positive phase 2 data is not only a prove of concept that ACP-104 targeting 5-HT receptors works on groups of schizophrenic patients while maintaining relatively safe profile, but is also indicative of the feasi...

Report this Post Replies: 0 | Reply | Permalink

RBBioContest06 (< 20) Submitted: 5/31/06 10:43 PM : Start Price: $10.33 ACAD Score: -65.87

Picked by dockofthebay

Report this Post Replies: 0 | Reply | Permalink

MCvest (< 20) Submitted: 7/12/07 9:04 PM : Start Price: $13.50 ACAD Score: -56.29

ACAD (VERY speculative, very up and down stock but I am betting on drug phase approval sending this stock up 100%)

Report this Post Replies: 0 | Reply | Permalink

BRKLMB (< 20) Submitted: 8/22/07 12:50 PM : Start Price: $14.93 ACAD Score: -63.74

Upside based on likely pharma partnership before end of 2007

Report this Post Replies: 0 | Reply | Permalink

razormd (52.18) Submitted: 10/17/07 12:58 PM : Start Price: $15.25 ACAD Score: -59.86

...I accidently had this listed as an "underperform"...I'm now correcting that...as I posted previously they have a lot of cash on hand...Allergan collaboration looks promising...pimavanserin moving steadily along...any drug development company is ri...

Report this Post Replies: 0 | Reply | Permalink

sdpowell (36.13) Submitted: 10/29/07 6:44 PM : Start Price: $15.16 ACAD Score: -59.74

huge potential for the drugs they offer, good chance of being acquired by a large company too

Report this Post Replies: 0 | Reply | Permalink

bobby410 (< 20) Submitted: 12/04/07 5:35 PM : Start Price: $11.63 ACAD Score: -55.81

Have a friend who works there, & things are looking very very good.

Report this Post Replies: 0 | Reply | Permalink

Cosmo21 (< 20) Submitted: 4/01/08 6:42 PM : Start Price: $9.38 ACAD Score: -55.25

ACAD is a strong buy at this level! Partnership on the way and the stock price will be back on it.s way to 17.

Report this Post Replies: 0 | Reply | Permalink